Literature DB >> 18394646

IL-10 modulates depressive-like behavior.

Ana Raquel Mesquita1, Margarida Correia-Neves, Susana Roque, António Gil Castro, Paulo Vieira, Jorge Pedrosa, Joana Almeida Palha, Nuno Sousa.   

Abstract

The role of pro-inflammatory cytokines in psychiatric disorders has been the focus of great research attention in recent years. Paradoxically, the same is not true for anti-inflammatory cytokines. In the present study, we assessed the behavioral profile of animals with altered expression of the anti-inflammatory cytokine IL-10. We performed a battery of tests to assess anxiety, depressive-like and cognitive behaviors in mice overexpressing IL-10 (PMT10) and IL-10(-/-) animals; in the later mice we also tested the behavioral effect of IL-10 administration. In the forced-swimming test, IL-10(-/-) females displayed increased depressive-like behavior; importantly, this phenotype was reverted by the injection of IL-10. Moreover, mice overexpressing IL-10 presented a decreased depressive-like behavior. Despite the presence of a similar trend, male animals did not reach significant differences in depressive-like behavior. Assessment in the open-field showed that the absence of IL-10 decreased the percentage of time spent in the center of the arena in both male and female mice, while male animals overexpressing IL-10 revealed an opposite behavior. For both sexes, imbalance in IL-10 levels did not affect spatial reference memory. In conclusion, variations in IL-10 expression are associated with an altered depressive-like behavior, but do not influence cognitive performance. Interestingly, IL-10 imbalance produced more profound behavioral changes in females than in male animals. This is in accordance with clinical data demonstrating an increased susceptibility of women to mood disorders, suggesting an interplay between anti-inflammatory cytokines and sexual steroids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18394646     DOI: 10.1016/j.jpsychires.2008.02.004

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  49 in total

1.  Corticotropin releasing factor-1 receptor antagonism alters the biochemical, but not behavioral effects of repeated interleukin-1β administration.

Authors:  Clare J Wilhelm; Aaron Murphy-Crews; Daniel J Menasco; Marilyn S Huckans; Jennifer M Loftis
Journal:  Neuropharmacology       Date:  2011-08-04       Impact factor: 5.250

Review 2.  Neuromodulation by the immune system: a focus on cytokines.

Authors:  Andrea Francesca Salvador; Kalil Alves de Lima; Jonathan Kipnis
Journal:  Nat Rev Immunol       Date:  2021-03-01       Impact factor: 53.106

Review 3.  Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets.

Authors:  Francis J Herman; Sherry Simkovic; Giulio M Pasinetti
Journal:  Br J Pharmacol       Date:  2019-03-21       Impact factor: 8.739

4.  Immune system inflammation in cocaine dependent individuals: implications for medications development.

Authors:  Helen C Fox; Carrol D'Sa; Anne Kimmerling; Kristen M Siedlarz; Keri L Tuit; Raymond Stowe; Rajita Sinha
Journal:  Hum Psychopharmacol       Date:  2012-03       Impact factor: 1.672

5.  Peripheral anti-inflammatory cytokine Interleukin-10 treatment mitigates interleukin-1β - induced anxiety and sickness behaviors in adult male rats.

Authors:  Soumyabrata Munshi; Victoria Parrilli; J Amiel Rosenkranz
Journal:  Behav Brain Res       Date:  2019-06-10       Impact factor: 3.332

6.  Late anxiety-like behavior and neuroinflammation in mice subjected to sublethal polymicrobial sepsis.

Authors:  Allan C Calsavara; David H Rodrigues; Aline S Miranda; Priscila A Costa; Cristiano X Lima; Márcia C Vilela; Milene A Rachid; Antônio L Teixeira
Journal:  Neurotox Res       Date:  2012-12-06       Impact factor: 3.911

7.  Healthy young women with serotonin transporter SS polymorphism show a pro-inflammatory bias under resting and stress conditions.

Authors:  Carolyn A Fredericks; Emily M Drabant; Michael D Edge; Jean M Tillie; Joachim Hallmayer; Wiveka Ramel; Janice R Kuo; Sean Mackey; James J Gross; Firdaus S Dhabhar
Journal:  Brain Behav Immun       Date:  2009-10-31       Impact factor: 7.217

8.  Optimizing the Exercise Prescription for Depression: The Search for Biomarkers of Response.

Authors:  Johnna L Medina; Jolene Jacquart; Jasper A J Smits
Journal:  Curr Opin Psychol       Date:  2015-04-01

9.  Effect of diclofenac and antidepressants on the inflammatory response in astrocyte cell culture.

Authors:  Md Mamun Al-Amin; Mir Muhammad Nasir Uddin; Md Mahbubur Rahman; Hasan Mahmud Reza; Md Sohel Rana
Journal:  Inflammopharmacology       Date:  2013-07-30       Impact factor: 4.473

10.  Interleukin-10: a key cytokine in depression?

Authors:  Susana Roque; Margarida Correia-Neves; Ana Raquel Mesquita; Joana Almeida Palha; Nuno Sousa
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.